372121-91-0

Basic information

• Product Name: 2-Fluoro-4-Nitrothioanisole
• Synonyms: 2-Fluoro-4-Nitrothioanisole;(2-FLUORO-4-NITROPHENYL)(METHYL)SULFANE
• CAS NO: 372121-91-0
• Molecular Formula: C₇H₆FNO₂S
• Molecular Weight: 187.1914432
• Mol File: 372121-91-0.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-Fluoro-4-Nitrothioanisole(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Fluoro-4-Nitrothioanisole(372121-91-0)
• EPA Substance Registry System: 2-Fluoro-4-Nitrothioanisole(372121-91-0)

Safety Data

• Hazardous Substances Data: 372121-91-0(Hazardous Substances Data)

Upstream product

• 369-34-6 3,4-difluoronitrobenzene 
• 5188-07-8 sodium thiomethoxide 

Downstream Products

• 851008-59-8 (2-fluoro-4-nitrophenyl)(imino)(methyl)-16-sulfanone 
• 20901-69-3 3-fluoro-4-(methylthio)benzeneamine 
• 1588945-01-0 4-((1S,2S)-2-(2-(3-fluoro-4-(methylsulfonyl)phenoxy)ethyl)cyclopropyl)piperidine 
• 1588945-00-9 benzyl 4-((1S,2S)-2-(2-(3-fluoro-4-(methylsulfonyl)phenoxy)ethyl)cyclopropyl)piperidine-1-carboxylate 
• 1447121-20-1 N-(2-(3-fluoro-4-(methylsulfonyl)phenoxy)ethyl)-1-(3-isopropyl-1,2,4-oxadiazol-5-yl)-N-methylpiperidine-4-amine trifluoroacetate 
• 1447121-17-6 N-(2-(3-fluoro-4-(methylsulfonyl)phenoxy)ethyl)-1-(3-isopropyl-1,2,4-oxadiazol-5-yl)-N-methylpiperidine-4-amine 
• 851008-47-4 C₇H₆FNO₃S 

Relevant articles and documents

ARYL SUBSTITUTED HETEROCYCLYL SULFONES

The invention relates to aryl substituted heterocyclyl sulfones as voltage gated calcium channel blockers, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.

SUBSTITUTED PIPERIDINE DERIVATIVES AND METHODS FOR PREPARING THE SAME

The present invention relates to a novel compound or a pharmaceutically acceptable salt thereof, a preparation method thereof and a pharmaceutical composition for treating metabolism-related disorder containing the same. Specifically, the present invention relates to a compound of the formula 1, which can activate GPR119 to treat metabolism-related disorders, including diabetes and related diseases, diabetes-related microvascular complications, diabetes-related macrovascular complications, cardiovascular abnormalities, metabolic syndrome and its constituent diseases, and obesity.

Macrocyclic anilinopyrimidines with substituted sulphoximine as selective inhibitors of cell cycle kinases

The invention relates to macrocyclic anilinopyrimidines with substituted sulphoximine of the general formula I, processes for their preparation, and their use as medicaments.